z-logo
open-access-imgOpen Access
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury
Author(s) -
José Manuel González-Rayas,
Ana Lilia RayasGómez,
José Juan GarcíaGonzález,
José Manuel González-Yáñez,
José A Hernández-Hernández,
R. López-Sánchez
Publication year - 2020
Publication title -
revista colombiana de cardiología
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 10
eISSN - 2357-3260
pISSN - 0120-5633
DOI - 10.1016/j.rccar.2020.04.005
Subject(s) - covid-19 , angiotensin receptor blockers , medicine , angiotensin converting enzyme , renin–angiotensin system , lung , angiotensin ii , ace inhibitor , pharmacology , peptidyl dipeptidase a , receptor , virology , disease , infectious disease (medical specialty) , outbreak , blood pressure

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom